Video Experimental Relacionado

Updated: Aug 15, 2025

HSV-Mediated Transgene Expression of Chimeric Constructs to Study Behavioral Function of GPCR Heteromers in Mice

HSV-Mediated Transgene Expression of Chimeric Constructs to Study Behavioral Function of GPCR Heteromers in Mice

Published on: July 9, 2016

Los psicodélicos y la señalización del receptor de serotonina

Ryan H Gumpper¹, Bryan L Roth¹

¹University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC 27599-7365, USA.

|January 7, 2023

Resumen

Los psicodélicos, que se dirigen al receptor de serotonina (5-hidroxitriptamina; 5HT) 5HT2A, son prometedores como nuevas terapias para los trastornos neuropsiquiátricos. Esta investigación explora su potencial para transformar los tratamientos para estas condiciones complejas.

Área de la Ciencia:

La neurociencia
Farmacología

Sus antecedentes:

La serotonina (5-hidroxitriptamina; 5HT) es un neurotransmisor clave que regula numerosos procesos fisiológicos y conductuales.
La desregulación de la señalización de 5HT está implicada en varios trastornos neuropsiquiátricos.

Objetivo del estudio:

Para investigar el potencial terapéutico de los psicodélicos dirigidos al receptor 5HT2A.
Explorar nuevas estrategias de tratamiento para enfermedades neuropsiquiátricas.

Principales métodos:

Revisión de la literatura existente sobre la señalización de la serotonina y la farmacología psicodélica.
Análisis del papel del receptor 5HT2A en los trastornos neuropsiquiátricos.

Principales resultados:

Los psicodélicos demuestran una afinidad específica para el receptor 5HT2A.
Esta interacción sugiere un mecanismo para sus efectos terapéuticos.

Conclusiones:

Dirigirse al receptor 5HT2A con psicodélicos representa una vía prometedora para el desarrollo de terapias transformadoras.
Se requiere más investigación para aclarar completamente sus aplicaciones clínicas.

Más Videos Relacionados

Rapid In Situ Hybridization using Oligonucleotide Probes on Paraformaldehyde-prefixed Brain of Rats with Serotonin Syndrome

Rapid In Situ Hybridization using Oligonucleotide Probes on Paraformaldehyde-prefixed Brain of Rats with Serotonin Syndrome

Published on: September 23, 2015

A Plate-Based Assay for the Measurement of Endogenous Monoamine Release in Acute Brain Slices

A Plate-Based Assay for the Measurement of Endogenous Monoamine Release in Acute Brain Slices

Published on: August 11, 2021

Videos de Conceptos Relacionados

CNS Stimulants: Psychedelic Agents

CNS Stimulants: Psychedelic Agents

Hallucinogens, also known as psychedelic drugs, are a class of substances known for their ability to alter perception, cognition, and emotions. Despite their profound effects on the mind, these drugs are non-addictive, setting them apart from many other abused substances. The mechanism of action of these drugs lies in their impact on the 5-HT2A receptor in the brain. Upon activation, this receptor couples to Gq-type G proteins, triggering a cascade that releases intracellular calcium. This...

Hallucinogens and Psychedelics

Hallucinogens and Psychedelics

Hallucinogens are psychoactive substances that profoundly alter perceptual experiences, generating unreal visual and sensory images. Often referred to as psychedelic drugs — a term derived from the Greek words "psyche" (mind) and "delos" (revealing) — these substances include marijuana and lysergic acid diethylamide (LSD), among others. These drugs vary in intensity and effects.
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...

G-protein Coupled Receptors

G-protein Coupled Receptors

G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.

Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists

Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists

Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...

Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders

Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders

Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...

Antidepressant Drugs: MAOIs and Other Agents

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...